InvestorsHub Logo
icon url

cheyenne1

03/12/12 12:37 PM

#24724 RE: skallywampus #24721

Frustrating that it sounds so good that as article states it decades away because of FDA.
Research has shown asprin used continually and at higher doses cause kidney failure and stomach erosion. But ok when used @83mg.

Pain relief is one thing but if this can help with the fight of cancer, should be a fast track method to get it approved.
My dad died 3yrs ago with stage 4 lung cancer that spread over his body and we just had my mother 1st chemo after a mastectomy. Going to be planned 2yr chemo.She has a 4cm spot inside liver.

The thought of anything or a product such as this hybrid asprin helping my kids and grandkids prevent this horror of a disease would be a blessing.

Good article and when i relate to PHARMSTAR and AQUAPRIN , whether or not the product has viability has not been 3rd party claimed and it has to get to market. I see that decades away under current system of trying based on current try coupled with past efforts, and the approach to getting it there.
But just as its ridiculous for the promise that a new hybrid asprin might help curb cancer could take a decade to use due to FDA,, its ridiculous to see a company driven into crapper by MGT and let that overshadow the product AQUAPRIN
Take care, good to hear from you, long time